| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 457,3 k € | +13.7% | 402,2 k € | +8.6% | 370,3 k € | -4.3% | 387,0 k € | -1.6% | 393,1 k € | +100.9% | 195,7 k € | -33.8% | 295,8 k € | +29.1% | 229,0 k € | -17.6% | 277,8 k € | +10.6% | 251,3 k € | -16.1% | 299,5 k € | +6.9% | 280,1 k € | -7.1% | 301,5 k € | +1.0% | 298,5 k € | +7.2% | 278,5 k € | -27.8% | 385,8 k € | |
| EBITDA | 451,3 k € | +12.9% | 399,6 k € | +8.8% | 367,4 k € | -4.4% | 384,4 k € | -1.9% | 391,9 k € | +101.7% | 194,3 k € | -33.9% | 293,8 k € | +29.5% | 226,9 k € | -17.4% | 274,7 k € | +9.9% | 250,1 k € | -16.2% | 298,5 k € | +7.0% | 279,0 k € | -7.1% | 300,4 k € | +1.3% | 296,5 k € | +7.2% | 276,7 k € | -27.4% | 381,3 k € | |
| Operating profit | 396,0 k € | +8.2% | 365,8 k € | +8.0% | 338,7 k € | -7.9% | 367,6 k € | +1.6% | 362,0 k € | +148.4% | 145,7 k € | -43.3% | 257,1 k € | +52.0% | 169,2 k € | -22.1% | 217,3 k € | +9.4% | 198,7 k € | -19.7% | 247,4 k € | +9.1% | 226,8 k € | -8.3% | 247,3 k € | +2.3% | 241,6 k € | +14.5% | 211,0 k € | -25.0% | 281,4 k € | |
| Profit/loss | 289,2 k € | +10.5% | 261,7 k € | +11.0% | 235,9 k € | -7.3% | 254,5 k € | -0.4% | 255,5 k € | +150.7% | 101,9 k € | -41.1% | 173,1 k € | +62.8% | 106,3 k € | -22.1% | 136,5 k € | +9.4% | 124,7 k € | -18.3% | 152,7 k € | -0.2% | 152,9 k € | -7.2% | 164,8 k € | +3.9% | 158,6 k € | +14.4% | 138,7 k € | -17.2% | 167,4 k € | |
| Equity | 807,4 k € | -28.6% | 1,1 M € | +8.5% | 1,0 M € | +14.2% | 911,9 k € | +14.7% | 795,0 k € | -2.7% | 817,0 k € | +14.2% | 715,1 k € | +31.9% | 542,0 k € | -6.6% | 580,3 k € | +30.8% | 443,8 k € | +39.1% | 319,1 k € | +91.7% | 166,4 k € | -51.3% | 342,0 k € | +93.0% | 177,2 k € | -44.4% | 318,5 k € | +77.1% | 179,8 k € | |
| Total assets | 1,4 M € | +7.1% | 1,3 M € | +14.8% | 1,2 M € | +6.4% | 1,1 M € | +14.7% | 954,3 k € | +16.2% | 820,9 k € | +10.5% | 743,1 k € | +32.4% | 561,3 k € | -10.2% | 625,1 k € | +32.4% | 472,3 k € | +21.0% | 390,3 k € | -21.1% | 494,9 k € | +29.1% | 383,4 k € | +13.7% | 337,3 k € | -14.1% | 392,9 k € | -10.3% | 437,8 k € | |
| Cash | 311,0 k € | -46.9% | 585,5 k € | +41.1% | 415,0 k € | +1885.5% | 20,9 k € | -80.4% | 106,8 k € | -17.7% | 129,8 k € | -53.9% | 281,4 k € | +13084.2% | 2,1 k € | -82.3% | 12,1 k € | +8.0% | 11,2 k € | -43.2% | 19,6 k € | +277.4% | 5,2 k € | +2.7% | 5,1 k € | -74.1% | 19,6 k € | +66.5% | 11,8 k € | +323.3% | 2,8 k € | |
| Debts | 623,3 k € | +202.0% | 206,4 k € | +69.1% | 122,0 k € | -32.9% | 181,8 k € | +14.5% | 158,7 k € | +4193.8% | 3,7 k € | -86.7% | 27,7 k € | +45.8% | 19,0 k € | -57.4% | 44,6 k € | +57.9% | 28,2 k € | -60.2% | 71,0 k € | -78.4% | 328,2 k € | +719.3% | 40,1 k € | -74.6% | 157,5 k € | +119.8% | 71,7 k € | -69.8% | 237,0 k € | |
Private limited company · Buggenhout · incorporated on 22/12/2008
Private limited company profitable and well capitalised. Cash position declining (-46.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR GEENS JEROEN is a Private limited company incorporated in 2008. Its main activity is: Other human health activities. Its registered office is in Buggenhout.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette